Article
Pfizer, Novartis and Roche are among the list of pharmaceuticals actively searching for a possible treatment to end the COVID-19 pandemic
by Miriam Bello
View from the Top
Fermín Valenzuela
Director
QBD Consulting
QBD Consulting began proposing new approaches to clinical research while using new technologies and operating under a risk management approach.
View from the Top
Louise Batchelder
CEO
Synelog Mexico
SYNELOG provides consulting in healthcare, education, social development, science and technology, innovation and competitiveness.
View from the Top
John Mitchell
Managing Partner of the Healthcare and Life Sciences Practice
Heidrick & Struggles
“It is necessary to establish a zero tolerance policy for non-compliance”
View from the Top
Francisco Corpi
Latin North Regional Director
Elsevier
Elsevier is a global information analytics company that helps institutions and professionals develop scientific health projects.
View from the Top
Justyna Kroplewska
Senior Consultant
Hays
Hays is one of the world’s leading recruitment companies with over 6,000 consultants in 33 countries working in 20 specialties
Insight
“We should have more than 1 percent of trials. We are close to the US, so we could act as a hub for processes that are currently being done in Panama”
The global contract research organization market is expected to reach a value of US$59 billion by 2020
Analysis
Mexico is trying to scale up its clinical research by taking advantage of its natural traits.
View from the Top
Xavier Ordoñez
Partner in Strategy and Operations Consulting
Deloitte
Deloitte is one of the world’s leading audit, consulting, tax, financial advisory and risk advisory brands.
Subscribe to BIG PHARMA